Steroid sparing drug treatments for giant cell arteritis
Editorial Group: Cochrane Musculoskeletal Group
Published Online: 21 JAN 2009
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Hill CL, Cole A, Lester S, Whittle SL. Steroid sparing drug treatments for giant cell arteritis (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD005323. DOI: 10.1002/14651858.CD005323.pub2.
- Publication Status: Edited (no change to conclusions)
- Published Online: 21 JAN 2009
This is the protocol for a review and there is no abstract. The objectives are as follows:
The aim of this systematic review is to document the quality and quantity of available evidence guiding practitioners in the use of glucocorticoid-sparing medications in the treatment of GCA. Specific objectives are:
- To assess the effectiveness of corticosteroid-sparing drug regimens